Sage Journals: Discover world-class research

Retricted access

Case report

First published 2022-8

Ototoxicity and Teprotumumab

Julie Highland, Steven Gordon, Deepika Reddy [...]

Annals of Otology,Rhinology & Laryngology

Retricted access

Case report

First published 2026-2

Beyond the Eyes: Is Teprotumumab Effective for Thyroid Dermopathy?

Dana Hamadi, Suhail Saad-Omer, David Toro-Tobon [...]

Thyroid®

Retricted access

Article commentary

First published 2021-12

Thyroid Eye Disease,Teprotumumab,and Hearing Loss: An Evolving Role for Otolaryngologists

Alexander Chern, Lora R. Dagi Glass, David A. Gudis

Otolaryngology–Head and Neck Surgery

Retricted access

Case report

First published 2022-5

Bilateral dysthyroid compressive optic neuropathy responsive to teprotumumab

Catherine J Hwang, Erin E Nichols, Brian H Chon [...]

European Journal of Ophthalmology

Retricted access

Research article

First published 2026-1

Corticosteroids Versus Teprotumumab for the Treatment of Thyroid Eye Disease. Does Either Mitigate the Need for Additional Treatments?

Suyoung Choi, Sarthak Vinay Shah, Patcharaporn Chandraparnik [...]

Thyroid®

Open access

Research article

First published 2025-10

Teprotumumab Treatment in Patients with Steroid and Surgery-Resistant Dysthyroid Optic Neuropathy: A Case Series

Anna Lucia Carretti, Gauthier Kielwasser, Françoise Borson-Chazot [...]

Thyroid®

Open access

Research article

First published 2024-07

Long-Term Efficacy of Teprotumumab in Thyroid Eye Disease: Follow-Up Outcomes in Three Clinical Trials

George J. Kahaly, Prem S. Subramanian, Elizabeth Conrad [...]

Thyroid®

Open access

Case report

First published 2022-4

Audiologic Demonstration of Ototoxicity From Teprotumumab Treatment in a Patient With Thyroid Eye Disease

Wassim Najjar, Jeffrey Yu

OTO Open

Retricted access

Research article

First published 2024-04

Teprotumumab Is Effective in Chronic and Inactive Thyroid Eye Disease

Giuseppe Barbesino

Clinical Thyroidology®

Retricted access

Research article

First published 2026-3

Beyond the Final Dose: The Chronic Glycemic Impact of Teprotumumab

David Toro-Tobon

Clinical Thyroidology®

Search results